Results 81 to 90 of about 76,010 (207)
, 2014 Percutaneous closure of a paravalvular leak is a challenging procedure that often presents with multiple simultaneous hurdles. We report a case of percutaneous retrograde paravalvular leak closure in a patient with a coexistent monoleaflet mechanical ...
Squillantini G +4 more
core +1 more source
A technique for repair of mitral paravalvular leak [PDF]
The Journal of Thoracic and Cardiovascular Surgery, 2004 lism. 3 Bioglue, which is composed of bovine serum albumin (45%) and gluteraldehyde (10%), is marketed as being less tissue toxic than GRF (gluteraldehyde 37%), and initial clinical experience was reported by Raanani and colleagues 4 in 2001. Polymerization occurs when the 2 components are mixed, reaching bonding strength within 2 minutes.
Mangi, Abeel A., Torchiana, David F.
openaire +2 more sources
Journal of Biomedical Materials Research Part A, Volume 114, Issue 8, August 2026.ABSTRACT Approaches to the structural design of tissue engineered heart valves (TEHVs) have varied broadly, ranging from material choice to microstructural and macro‐scale functional characteristics. Not only will each variable on this extensive list impact functional and restorative potential after implantation, but most of these variables also have ...
Drake D. Pedersen +11 more
wiley +1 more source
Contemporary Management of Aortic Stenosis: Timing of Intervention and Lifetime Valve Management
European Journal of Clinical Investigation, Volume 56, Issue 8, August 2026.As transcatheter treatment expands to younger and lower‐risk patients, aortic stenosis management is evolving from a single procedure to lifelong valve care. This review highlights the key challenges across the patient journey, from timely diagnosis and optimal intervention to durable valve performance, long‐term surveillance, and repeat intervention ...
Ottavia Cozzi, Thomas Pilgrim
wiley +1 more source
Transcatheter paravalvular leak closure and hemolysis – a prospective registry
, 2016 Introduction : Paravalvular leak (PVL) related to a surgical prosthetic valve may be associated with clinically significant hemolysis. The influence of transcatheter PVL closure (TPVLC) on hemolysis remains uncertain.
Michał Tendera +7 more
core +1 more source
Catheterization and Cardiovascular Interventions, Volume 108, Issue 1, Page 144-162, July 1, 2026.ABSTRACT Background Transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BAV) anatomy remains challenging due to anatomical complexity and limited trial data. New‐generation balloon‐expandable valves, such as Myval, require further evaluation in this subgroup.
Balázs Magyari +11 more
wiley +1 more source
Redo AVR for Paravalvular Leak Following TAVR
, 2021 This is an 82-year-old gentlemen with severe ostial LAD stenosis, paroxysmal atrial fibrillation, and para-valvular leak in a 2-year-old TAVR valve. The operation was performed via median sternotomy, which was followed by harvesting of the left internal ...
Lamees I. El Nihum (11635987) +2 more
core +1 more source
Catheterization and Cardiovascular Interventions, Volume 107, Issue 7, Page 2179-2182, June 1, 2026.ABSTRACT Paravalvular leak (PVL) is a recognized complication after surgical mitral valve replacement and may cause heart failure, pulmonary hypertension, or hemolysis when moderate or severe. Although redo surgery is the definitive treatment, it carries substantial risk in elderly patients or those with multiple prior cardiac surgeries.
Marco Garaventa +3 more
wiley +1 more source
Percutaneous Closure of Prosthetic Paravalvular Leaks
Reviews in Cardiovascular Medicine, 2012 Paravalvular leaks (PVLs) are relatively common after valve replacement. These leaks are usually small and disappear during the follow-up. Symptomatic PVLs occur in 1% to 2% of patients undergoing valve replacement. PVLs causing clinical consequences require surgical intervention. Surgery is considered the gold standard of dehiscence repair.
Maciej, Grabowski +3 more
openaire +2 more sources
Early Outcomes of Real‐World Aortic Valve Replacement With RESILIA Tissue in the Chinese Population
Clinical Cardiology, Volume 49, Issue 6, June 2026.In this real‐world study of 250 Chinese patients scheduled for elective aortic valve replacement, the INSPIRIS RESILIA aortic valve demonstrated favorable 1‐year safety, with a 98.0% rate of freedom from all‐cause mortality and no observed structural valve deterioration, alongside stable hemodynamic performance.
Haitao Xu +4 more
wiley +1 more source